Rivastigmin Sandoz 4,6 mg/24 Stunden - transdermales Pflaster
Active ingredient: RIVASTIGMIN
View notice details →
News topic
Current shortage notices for the active ingredient RIVASTIGMIN, structured by product, country and reporting period.
3 noticesActive ingredient: RIVASTIGMIN
View notice details →Active ingredient: RIVASTIGMIN
View notice details →Active ingredient: RIVASTIGMIN
View notice details →